Encelimab (Anti-LAG3 / CD223)
Encelimab (Anti-LAG3 / CD223) is a humanized monoclonal antibody targeting the inhibitory receptor lymphocyte activation gene 3 protein (LAG3). It has potential immune checkpoint inhibitory and antineoplastic, antitumor activity. MW :144.58 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2993 |
Sku # | A2993-1mg |
Pricing | 1mg, $539.00 |